Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity.

Publication Date: 2024 Sep 01


Full Text Sources

Ovid Technologies, Inc.

PubMed Central (Free)

Europe PubMed Central (Free)

Silverchair Information Systems (Free)

Related Articles


Authors

Patricia J Rodriguez; Brianna M Goodwin Cartwright; Samuel Gratzl; Rajdeep Brar; Charlotte Baker; Ty J Gluckman; Nicholas L Stucky

Abstract

OBJECTIVE

Although tirzepatide and semaglutide were shown to reduce weight in randomized clinical trials, data from head-to-head comparisons in populations with overweight or obesity are not yet available.


Source

JAMA internal medicine


Pub Types(s)

Journal Article


Language

English


PubMed ID

38976257